Bids Are Invited For Acquisition Of High-Cost Medicines Rms2 Pe 86/2023

Acquisition Of High-Cost Medicines Rms2 Pe 86/2023. A Citretin,Acitretin,Adalimumab,Aflibercept,Epoetin Alfa, Epoetin Alfa,Epoetin Alfa,Alphathyrotropin,Apalutamide,Aripiprazole,Aripiprazole,Aripiprazole,Asparaginase,Azacytidine,Bevacizumab,Bevacizumab,Bicalutamide,Bleomycin Sulfate,Blinatumomab,Bortezomib,Bosentan,Brentuximab Vedotin,Galantamine,Galantamine,Galantamine,Busulfan,C Abazitaxel,Cabergoline,Medicinal Extract ,Capecitabine,Carboplatin,Carboplatin,Ferric Carboxymaltose,Carfilzomib,Carmustine,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cyclophosphamide,Cyclosporine,Cyclosporine,Cyclosporine,Cisplatin,Cytarabine,Cytarabine,Cytarabine,Ixazomib,Tofacitinib,Sildenafil, Cladribine,Cladribine,Chlorambucil,Oxycodone Hydrochloride ,Daunorubicin,Anagrelide Hydrochloride,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Epirubicin Hydrochloride,Gemcitabine Hydrochloride,Gemcitabine Hydrochloride,Idarubicin Hydrochloride,Irinotecan Hydrochloride,Mitoxantrone Hydrochloride,Palonosetron Hydrochloride,Pazopanib,Pazopanib,Pona Tinib,Topotecan Hydrochloride,Erlotinib,Methylphenidate Hydrochloride,Clozapine,Crizotinib ,Dacarbazine,Daratumumab,Daratumumab,Darolutamide,Dasatinib,Zuclopenthixol,Decitabine,Deferasirox,Denosumab,Pramipexole,Pramipexole,Lapatinib,Docetaxel,Docetaxel